Breast cancer identity is defined by specialized enhancer sets via lysine deacetylation
Hiroaki Tachiwana, Kohei Kumegawa, Ryota Matsudo, Ai Katsuma, Atsushi Okabe, Nao Yoshida, Xufeng Shu, Masaki Kato, Tamiko Minamisawa, Akihiro Ito, Hiroshi Kimurâ, Piero Carninci, Atsushi Kaneda, Yasukazu Daigaku, Reo Maruyama, Noriko Saitoh
The paper identifies hypoacetylation-defined enhancers in luminal breast cancer cells and links them to subtype-specific gene regulation and patient classification.
bioRxiv · Jul 31, 2025 · PreprintCancer Biology